Skip header and navigation
The BC Cancer Library

Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.

Refine by:

2 records – page 1 of 1.

Quick guide to good clinical practice : how to meet international quality standard in clinical research

https://bccalibrary.andornot.com/en/permalink/catalog120841
Cingi, Cemal, Muluk, Nuray Bayar. Cham, Switzerland: Springer , 2016.
Audience
Professional
Table of Contents:; Chapter 1: Clinical Trials: Historical Aspects and Importance and New Drug Developments -- Chapter 2: The Definition of GCP -- Chapter 3: The Principles of GCP -- Chapter 4: The Drug Development Process and Evolution of Regulations -- Chapter 5: Planning Clinical Research -- Cha…
  1 read online  
Alternate Title
How to meet international quality standard in clinical research
Author
Cingi, Cemal
Muluk, Nuray Bayar
Place of Publication
Cham, Switzerland
Publisher
Springer
Publication Date
2016
Series
EBSCOhost eBook
Subjects
Clinical Trials as Topic
Biomedical Research
Ethics, Research
Data Accuracy
Total Quality Management - standards
Internationality
Practice Guideline
Abstract
Table of Contents:
Chapter 1: Clinical Trials: Historical Aspects and Importance and New Drug Developments -- Chapter 2: The Definition of GCP -- Chapter 3: The Principles of GCP -- Chapter 4: The Drug Development Process and Evolution of Regulations -- Chapter 5: Planning Clinical Research -- Chapter 6: Preparation of Ethics Committee (IRB) Proposal -- Chapter 7: Preparation of Informed Consent -- Chapter 8: Preparation of Findings Tables -- Chapter 9: Setting the Ideal Statistical Methods -- Chapter 10: The Duties of a Clinical Research Coordinator
-- Chapter 11: The Duties of Clinical Researchers -- Chapter 12: The Phases of Clinical Studies -- Chapter 13: Safety in Clinical Trials -- Chapter 14: Setting the Size -- Chapter 15: Setting the Ideal Method -- Chapter 16: Ethics of Clinical Research -- Chapter 17: Recruitment and Enrolment -- Chapter 18: Why We Need Clinical Consent and Other Documentation -- Chapter 19: Monitoring the Trial -- Chapter 20: Inspection -- Chapter 21: Ethics: Institutional Review Board/Independent Ethics Committee (IRB/IEC) -- Chapter 22: Responsibilities of the Investigator -- Chapter 23: Responsibilities of the Sponsor -- Chapter 24: Clinical Trial Protocols
ISBN
9783319443430
9783319443447
Language
English
Material Type
Ebook
Audience
Professional
Location
Internet
Website Notes
This EBSCO title is licensed for one BC Cancer staff user at a time only. Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.
Read Online
Show Less

Malignant : how bad policy and bad evidence harm people with cancer

https://bccalibrary.andornot.com/en/permalink/catalog123037
Prasad, Vinayak K. Baltimore, MD: John Hopkins University Press , 2020.
Audience
Professional
"In this critical study of current cancer therapies, Dr. Prasad, an oncologist and hematologist, examines oncology practice and policy in the United States. His book is organized into four sections: (1) an overview of cancer drugs, (2) forces that distort cancer medicine and practice, (3) details a…
  1 read online  
Author
Prasad, Vinayak K.
Place of Publication
Baltimore, MD
Publisher
John Hopkins University Press
Publication Date
2020
Series
Proquest Ebook Central
Subjects
Neoplasms - drug therapy
Antineoplastic Agents - economics
Biomedical Research - economics
Drug Development - economics
Health Policy
Patient rights
United States
Abstract
"In this critical study of current cancer therapies, Dr. Prasad, an oncologist and hematologist, examines oncology practice and policy in the United States. His book is organized into four sections: (1) an overview of cancer drugs, (2) forces that distort cancer medicine and practice, (3) details about cancer research and practice, (4) recommended solutions on multiple levels (policy, practitioners, medical education, and pharmacology)"-- Provided by publisher.
Contents:
The Basics of Cancer Drugs : Cost, Benefit, Value -- Surrogate Endpoints in Cancer : What Are They and Where Are They Used? -- Use and Misuse of Surrogates for Drug Approvals -- How High Prices Harm Patients and Society -- Hype, Spin, and the Unbridled Enthusiasm That Distorts Cancer Medicine -- Financial Conflict of Interest -- The Harms of Financial Conflicts and How to Rehabilitate Medicine -- Will Precision Oncology Save Us? -- Study Design -- Principles of Oncology Practice -- Important Trials in Oncology -- Global Oncology -- How Should Cancer Drug Development Proceed? -- What Can the US Food and Drug Administration and the Centers for Medicare and -- Medicaid Services Do Tomorrow? -- What Can People with Cancer Do? -- What Can Students, Residents, and Fellows Do?
ISBN
9781421437637
9781421437644
Language
English
Material Type
Ebook
Audience
Professional
Location
Internet
Website Notes
This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.
Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.
Read Online
Show Less